Liver and Fat Regulation in Overweight Adolescent Girls

• Status: Active, not recruiting
• Trial end date: 2021-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Women with polycystic ovarian syndrome (PCOS) have increased rates of hepatic steatosis compared to weight similar women with regular menses. It is unclear if this is related to high testosterone or insulin resistance. The investigators will assess hepatic glucose release, rates of lipolysis and hepatic de novo lipogenesis in the fasted and postprandial state to determine if alterations in the processes contribute to hepatic steatosis. Participants will be overweight, sedentary girls with or without PCOS. Those with PCOS will either be medication naive, or must be taking metformin or combined oral contraceptives (COCPs) for a period of at least 6 months prior to study procedures.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Colorado, Denver
• Treatments: Exenatide

Criteria

Inclusion Criteria:

• Females

• 2 years post-menarche

• BMI percentile >90%

Exclusion Criteria:

• Type 2 diabetes

• Anemia

• Liver disease

• Medications known to effect insulin sensitivity

• Cause of oligomenorrhea or hirsutism other than PCOS,

• >3 hours a week of moderate exercise.